CMND
Income statement / Annual
Last year (2024), Clearmind Medicine Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Clearmind Medicine Inc.'s net income was -$5.25 M.
See Clearmind Medicine Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
10/31/2024 |
10/31/2023 |
10/31/2022 |
10/31/2021 |
10/31/2020 |
10/31/2019 |
10/31/2018 |
10/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$26,703.00
|
$56,342.00
|
$113,379.00
|
$2,572.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$26,703.00
|
-$56,342.00
|
-$113,379.00
|
-$2,572.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.38 M
|
$2.14 M
|
$2.98 M
|
$646,487.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$3.26 M
|
$6.60 M
|
$5.43 M
|
$3.03 M
|
$233,220.00
|
$105,283.00
|
$254,535.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.35 M
|
$6.60 M
|
$5.43 M
|
$3.03 M
|
$233,220.00
|
$105,283.00
|
$254,535.00
|
$6,671.00
|
| Other Expenses |
$0.00
|
$0.00
|
$113,378.00
|
$0.00
|
$0.00
|
$0.00
|
$60,000.00
|
$0.00
|
| Operating Expenses |
$5.72 M
|
$8.74 M
|
$8.53 M
|
$3.68 M
|
$233,220.00
|
$105,283.00
|
$254,535.00
|
$6,671.00
|
| Cost And Expenses |
$2.57 M
|
$8.74 M
|
$8.53 M
|
$3.68 M
|
$233,220.00
|
$105,283.00
|
$254,535.00
|
$6,671.00
|
| Interest Income |
$271,224.00
|
$57,972.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$36,160.00
|
$0.00
|
$19,678.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$51,072.00
|
$30,687.00
|
$113,379.00
|
$2,572.00
|
$179,689.00
|
$86,005.00
|
$161,141.00
|
$0.00
|
| EBITDA |
-$5.85 M |
-$8.71 M |
-$8.49 M |
-$3.67 M |
-$233,220.00 |
$0.00 |
-$56,272.00 |
-$6,670.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.03 M
|
-$3.19 M
|
-$835,858.90
|
-$43,528.00
|
-$179,689.00
|
$0.00
|
$60,000.00
|
-$1.00
|
| Income Before Tax |
-$4.88 M
|
-$11.93 M
|
-$9.37 M
|
-$3.90 M
|
-$233,220.00
|
-$105,283.00
|
-$194,535.00
|
-$6,671.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$377,966.00
|
$24,090.00
|
$40,754.00
|
$223,218.00
|
-$385,986.00
|
-$171,863.00
|
-$60,000.00
|
$0.00
|
| Net Income |
-$5.25 M
|
-$11.96 M
|
-$9.41 M
|
-$4.12 M
|
-$233,220.00
|
-$105,283.00
|
-$194,535.00
|
-$6,671.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.695 |
-42.5757 |
-168.6133 |
-95.6735 |
-9.5562 |
-6.4213 |
-14.018 |
-0.4196 |
| EPS Diluted |
-1.695 |
-42.5757 |
-168.6133 |
-95.6735 |
-9.5562 |
-6.4213 |
-14.018 |
-0.4196 |
| Weighted Average Shares Out |
$4.27 M
|
$2.02 M
|
$433,340.00
|
$309,110.00
|
$181,300.00
|
$123,330.00
|
$107,790.00
|
$122,220.00
|
| Weighted Average Shares Out Diluted |
$4.27 M
|
$2.02 M
|
$433,340.00
|
$309,110.00
|
$181,300.00
|
$123,330.00
|
$107,790.00
|
$122,220.00
|
| Link |
|
|
|
|
|
|
|
|
